Advertisement

Related Videos

Opening Session Panel Discussion

Focus on Optimized Dosing of Ibrutinib Panel Discussion

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Amit Sanyal, MD: A Clinician’s Perspective

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Advertisement

Advertisement




Apr
30
Today In Oncology
AI-Powered, Next-Generation Sequencing Blood-Based Assay Evaluated for Detection of Post-HCT Relapse in AML and MDS
MIBC Pembrolizumab With Trimodal Therapy for Bladder Preservation
Long-Term Outcomes With Taletrectinib in ROS1-Positive NSCLC
Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer
Study Finds Prostate Cancer Overdiagnosis Rises ‘Substantially’ With Age
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo